June 2, 2025

Revvity, Inc. (RVTY) Investor Outlook: Navigating a 38% Potential Upside in the Lucrative Healthcare Sector

Revvity, Inc. (NYSE: RVTY), a stalwart in the diagnostics and research industry, is making waves in the healthcare sector with an impressive market capitalization of $10.66 billion. Formerly known as..

Waters Corporation (WAT) Stock Analysis: A Healthcare Powerhouse with 11% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the Diagnostics & Research industry within the healthcare sector, continues to capture the interest of investors due to its robust performance metrics..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 79.58% Potential Upside Amidst Market Challenges

Investors eyeing opportunities in the biotechnology sector might find Moderna, Inc. (NASDAQ: MRNA) a compelling yet complex investment case. The company, well-known for its pioneering work in messenger RNA (mRNA)..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a 7.78% Potential Upside in the Diagnostics & Research Space

Mettler-Toledo International, Inc. (NYSE: MTD) stands as a formidable player in the global healthcare sector, specifically within the diagnostics and research industry. Headquartered in Columbus, Ohio, this company has carved..

Hologic, Inc. (HOLX) Stock Analysis: A Healthcare Powerhouse with an 8% Upside Potential

Hologic, Inc. (NASDAQ: HOLX) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for its focus on women’s health, Hologic has established..

Biogen Inc. (BIIB) Stock Analysis: A Glimpse into the 32% Potential Upside

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, presents an intriguing proposition for investors, underscored by its promising therapies for neurological and neurodegenerative diseases. Based in Cambridge, Massachusetts,..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Potential 37.78% Upside Sparks Investor Interest

Teva Pharmaceutical Industries (TEVA), a prominent player in the healthcare sector, is making waves among investors due to its substantial potential upside of 37.78%. Headquartered in Tel Aviv, Israel, Teva..

GE HealthCare Technologies Inc. (GEHC): Investor Outlook Reveals 23.69% Potential Upside Amid Robust Analyst Ratings

GE HealthCare Technologies Inc. (NYSE: GEHC), a heavyweight in the Health Information Services industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating a Potential 18.32% Upside

Universal Health Services, Inc. (NYSE: UHS) is a notable player in the healthcare sector, with a strong foothold in the medical care facilities industry. Headquartered in King of Prussia, Pennsylvania,..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 41.78% Potential Upside in the Healthcare Arena

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the medical devices industry, is making headlines with its significant potential upside of 41.78% as indicated by the average target price..

DexCom, Inc. (DXCM) Stock Analysis: Evaluating Growth Potential with a 14.74% Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the medical devices sector, has been capturing investor attention with its innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, DexCom..

Becton, Dickinson and Company (BDX): Investor Outlook on a 29% Potential Upside Amidst Strong Analyst Confidence

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust medical instruments and supplies business. With a market..

AstraZeneca PLC (AZN) Stock Analysis: Navigating a 15.59% Potential Upside Amid Robust Dividend Yield

AstraZeneca PLC (AZN), a leading biopharmaceutical giant based in Cambridge, United Kingdom, stands out in the healthcare sector with an impressive market capitalization of $225.8 billion. Known for its innovation..

Cencora, Inc. (COR): Investor Outlook Highlights 8.92% Potential Upside

Cencora, Inc. (COR), a prominent player in the healthcare sector specializing in medical distribution, is drawing considerable attention from investors. With its roots tracing back to 1871 and a recent..

Tenet Healthcare Corporation (THC) Stock Analysis: A Healthcare Giant with a 6.47% Upside Potential

Tenet Healthcare Corporation (NYSE: THC), a stalwart in the medical care facilities industry, offers investors a unique blend of stability and growth potential. Headquartered in Dallas, Texas, with a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 107% Upside Potential in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical leader based in Miami, Florida, has become a focal point for investors keen on the biotechnology sector. With a market capitalization of $13.53..

West Pharmaceutical Services, Inc. (WST) Investor Outlook: Exploring a 33.71% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a leading player in the healthcare sector, specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products. With a..

Edwards Lifesciences (EW) Stock Analysis: Navigating the Heart of the Medical Device Market with a 3.51% Upside

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the medical devices sector, stands as a beacon of innovation in the treatment of advanced cardiovascular diseases. With a robust market capitalization..

Novartis AG (NVS) Stock Analysis: Evaluating Earnings Growth Potential with a Strong Return on Equity

Novartis AG (NVS), a prominent player in the global healthcare sector, is a Swiss-based pharmaceutical giant renowned for its innovative drug manufacturing and robust research and development capabilities. With a..

GSK plc (GSK) Stock Analysis: Exploring Growth Potential with a Robust 3.90% Dividend Yield

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as a major player within the drug manufacturers’ industry. Headquartered in London, the company has established a global footprint..

Search

Funds

June 2, 2025

Search

Funds

June 2, 2025

FTSE 100

Funds